DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Clolar (Clofarabine) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Clolar side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-25

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in

Reported by a consumer/non-health professional from United States on 2012-04-09

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in

Reported by a pharmacist from United States on 2012-04-02

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in

Reported by a pharmacist from United States on 2012-03-30

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in

Reported by a physician from United States on 2012-03-30

Patient:

Reactions: Death, Fall

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in

Reported by a physician from United States on 2012-03-09

Patient:

Reactions: Death, Fall

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar



Possible Clolar side effects in 6 year old female

Reported by a physician from Argentina on 2011-10-17

Patient: 6 year old female

Reactions: Death, Sepsis, Haematotoxicity

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 40 mg/m2, qdx5 (cycle 1)
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2010-11-02

Cyclophosphamide
    Dosage: unk (cycle 1)
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2010-11-02

Clolar
    Dosage: 40 mg/m2, qdx5 (cycle 2)

Cyclophosphamide
    Dosage: unk (cycle 2)

Etoposide
    Dosage: unk (cycle 1)
    Indication: Acute Lymphocytic Leukaemia Recurrent
    Start date: 2010-11-02

Etoposide
    Dosage: unk (cycle 2)



Possible Clolar side effects in 11 year old female

Reported by a physician from Colombia on 2011-10-11

Patient: 11 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Large Intestine Perforation, Neutropenic Colitis, Stomatitis, Anaemia, Febrile Neutropenia, Pyrexia, Klebsiella Bacteraemia, Death, Thrombocytopenia, Sinusitis, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Clolar
    Dosage: 60 mg (52 mg/m2), qdx5 (cycle 1)
    Indication: Acute Lymphocytic Leukaemia

Clolar
    Dosage: 60 mg (52 mg/m2), qdx5 (cycle 2)

Other drugs received by patient: Hydrocortisone; Ondansetron; Acetaminophen; Hydroxyzine; Ranitidine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017